Impact of Busulfan Exposure on Transplant Outcomes for Patients with Advanced Myelodysplastic Syndrome Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation.

Subjects

Subjects :

*MYELODYSPLASTIC syndromes
*BUSULFAN
*HEALTH outcome assessment
*CD34 antigen
*HEMATOPOIETIC stem cell transplantation
*PATIENTS

Details

Language :

English

ISSN :

10838791

Volume :

22

Database :

Academic Search Index

Journal :

Biology of Blood & Marrow Transplantation

Publication Type :

Academic Journal

Accession number :

112389963

Full Text :

https://doi.org/10.1016/j.bbmt.2015.11.841